How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

4,433 results for

Counseling in HIV Infection

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

4161. Effectiveness of HIV/Sexually Transmitted Infection Training for Physicians in China

Intervention/treatment Phase HIV Infections Gonorrhea Chlamydia Behavioral: Physician Ai Shi Zi training Drug: Standard care Behavioral: Patient risk-reduction counseling Not Applicable Detailed Description: HIV and sexually transmitted infections (STIs) are among the foremost public health concerns worldwide, with the number of infections continuing to rise significantly. Specifically, in China, the number of cases of HIV is estimated to rise from 650,000 in 2006 to more than 10 million by the year 2010 (...) /STI prevention and treatment. The Ai Shi Zi program, which provides training on stigma, risk-reduction counseling methods, and treatment skills to county and township level physicians in China, may be an effective means of implementing HIV/STI training. This study will evaluate the effectiveness of the Ai Shi Zi program in improving HIV/STI diagnosis, treatment, and management by Chinese physicians and in reducing the number of subsequent HIV/STI infections in their patients. Participants

2008 Clinical Trials

4162. Observational Study of HIV Infected Women Previously Enrolled in Other Microbicide Trials

diagnosis and can leave the study at any time. A physical exam; medical and medication history assessment; blood and urine collection; and pelvic, cervicovaginal lavage, and vaginal swab sampling will occur at all visits. A behavioral assessment will occur at select visits, and adherence and social harms assessments will occur at most visits. Sexually transmitted infection risk reduction/contraception and HIV-1 secondary counseling will occur at most visits. In addition, condoms will be provided at all (...) Network: Microbicide Seroconversion Treatment Experienced Treatment Naive Additional relevant MeSH terms: Layout table for MeSH terms HIV Infections Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases Anti-Infective Agents

2007 Clinical Trials

4163. Safety and Immunogenicity of GlaxoSmithKline Biologicals' HPV Vaccine 580299 (Cervarix TM) in HIV Infected Females

: Randomized Intervention Model: Parallel Assignment Masking: Double (Participant, Investigator) Primary Purpose: Prevention Official Title: Evaluation of the Safety and Immunogenicity of GlaxoSmithKline Biologicals' HPV Vaccine 580299 (Cervarix TM) in Adult Human Immunodeficiency Virus (HIV) Infected Female Subjects Study Start Date : January 17, 2008 Actual Primary Completion Date : July 18, 2011 Actual Study Completion Date : July 18, 2011 Resource links provided by the National Library of Medicine (...) on this site. Keywords provided by GlaxoSmithKline: HPV Human papillomavirus (HPV) vaccine Human Immunodeficiency Virus (HIV) Cervical cancer Papillomavirus Additional relevant MeSH terms: Layout table for MeSH terms Acquired Immunodeficiency Syndrome HIV Infections Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Slow Virus Diseases Immunologic Deficiency Syndromes Immune System Diseases Vaccines Aluminum

2007 Clinical Trials

4164. Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected Subjects

: May 18, 2009 Sponsor: GlaxoSmithKline Information provided by: GlaxoSmithKline Study Details Study Description Go to Brief Summary: The purpose of this study is to evaluate the safety and efficacy of the CCR5 antagonist GW873140 or placebo in combination with an optimized background regimen in treatment-experienced HIV-infected subjects with R5-tropic virus Condition or disease Intervention/treatment Phase HIV Infection Drug: GW873140 Phase 3 Study Design Go to Layout table for study information (...) to these criteria, investigators must exercise clinical discretion regarding selection of appropriate study subjects, taking into consideration any local treatment practices or guidelines. A subject will be eligible for inclusion in the CCR104456 protocol only if all of the following criteria apply: HIV-1 infected subjects aged 18 years or older. All subjects participating in this study should be counseled on the practice of safe sex throughout the study. Females must fall into one of the following categories

2006 Clinical Trials

4165. Acute HIV Infection Observational Study

of Allergy and Infectious Diseases (NIAID) ClinicalTrials.gov Identifier: Other Study ID Numbers: CHAVI 001 First Posted: February 27, 2006 Last Update Posted: November 19, 2013 Last Verified: November 2013 Keywords provided by National Institute of Allergy and Infectious Diseases (NIAID): Acute Infection Additional relevant MeSH terms: Layout table for MeSH terms Infection Communicable Diseases HIV Infections Acquired Immunodeficiency Syndrome Lentivirus Infections Retroviridae Infections RNA Virus (...) of acute HIV infections. One system using such strategies has already been implemented in North Carolina, and this system will be used in this study run by the Center of HIV/AIDS Vaccine Immunology (CHAVI). This study will collect data on the mechanism of HIV transmission and the genetic, biologic, antigenic, and structural characteristics of the virus. The study will enroll HIV infected people with acute HIV infection and their sexual partners, people with established HIV infection, and HIV uninfected

2006 Clinical Trials

4166. Stepping Stones Program for Preventing HIV Infection in Residents of Rural South African Communities

to prevent HIV infection by modifying sexual behaviors. Voluntary counseling and testing have been shown to have an important impact on sexual behavior, but it is essential that other approaches to HIV prevention are developed and evaluated. Little research, however, has been done on behavioral interventions, relative to the amount of research that has been devoted to biotechnology development. Stepping Stones is an approach to HIV prevention that aims to improve sexual health through building stronger (...) Infections Acquired Immunodeficiency Syndrome Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases Slow Virus Diseases

2006 Clinical Trials

4167. BLADE: Comparison of Once Daily Lopinavir/Ritonavir to Lopinavir/Ritonavir BID Dosing in HIV-Infected Subjects

Posted: January 11, 2007 Last Verified: October 2006 Keywords provided by Bellos, Nicholaos C., M.D.: HIV Infected Additional relevant MeSH terms: Layout table for MeSH terms HIV Infections Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases Lopinavir HIV Protease Inhibitors Protease Inhibitors Enzyme Inhibitors Molecular Mechanisms (...) BLADE: Comparison of Once Daily Lopinavir/Ritonavir to Lopinavir/Ritonavir BID Dosing in HIV-Infected Subjects BLADE: Comparison of Once Daily Lopinavir/Ritonavir to Lopinavir/Ritonavir BID Dosing in HIV-Infected Subjects - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved

2006 Clinical Trials

4168. A Study to Compare Three Existing Starting Points of Anti-Retroviral Therapy (ART) Initiation in HIV/Tuberculosis (TB) Co-infected Patients

includes extensive counselling and adherence support. The study participants will be followed for 18 months to assess the primary study endpoint of the optimal time to start antiretroviral therapy (ART) in patients on tuberculosis (TB) treatment by comparing clinical status (CD4+ cell count, viral load, opportunistic infections. Condition or disease Intervention/treatment Phase HIV Infections Tuberculosis Drug: Early versus intermediate versus late initiation of ART Phase 3 Study Design Go to Layout (...) A Study to Compare Three Existing Starting Points of Anti-Retroviral Therapy (ART) Initiation in HIV/Tuberculosis (TB) Co-infected Patients A Study to Compare Three Existing Starting Points of Anti-Retroviral Therapy (ART) Initiation in HIV/Tuberculosis (TB) Co-infected Patients - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study

2006 Clinical Trials

4169. Observational Cohort of HIV Infected Adults and Children in the PHPT Network Hospitals in Thailand

. To determine factors associated with treatment outcome including immune status, virologic factors and antiretroviral drugs levels To study the operational aspects of integrating comprehensive HIV care into the existing care system with regards to new activities generated at the hospital level (counseling, referral systems, biological monitoring), the impact on other health activities, mobilization of human and financial resources, affordability and sustainability. The population of the study consists (...) Observational Cohort of HIV Infected Adults and Children in the PHPT Network Hospitals in Thailand Observational Cohort of HIV Infected Adults and Children in the PHPT Network Hospitals in Thailand - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove

2007 Clinical Trials

4170. HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults

compared to fosamprenavir/ritonavir 700mg/100mg BID and 2) a superior fasting non-HDL lipid profile in subjects receiving fosamprenavir/ritonavir 1400mg/100mg QD. Condition or disease Intervention/treatment Phase Infection, Human Immunodeficiency Virus I HIV-1 Infection Drug: fosamprenavir/ritonavir Phase 3 Study Design Go to Layout table for study information Study Type : Interventional (Clinical Trial) Actual Enrollment : 212 participants Allocation: Randomized Intervention Model: Parallel Assignment (...) Identifier: Other Study ID Numbers: APV109141 First Posted: March 22, 2007 Results First Posted: September 2, 2009 Last Update Posted: June 7, 2012 Last Verified: April 2012 Keywords provided by ViiV Healthcare: protease inhibitor, HIV-1, Fosamprenavir, non-HDL cholesterol ritonavir, naive, Additional relevant MeSH terms: Layout table for MeSH terms Infection Communicable Diseases Immunologic Deficiency Syndromes Acquired Immunodeficiency Syndrome HIV Infections Immune System Diseases Lentivirus

2007 Clinical Trials

4171. The Pharmacokinetics and Safety of IDV/r With NRTIs in HIV/TB Co-infected Patients Receiving Rifampicin

Retroviridae Infections RNA Virus Infections Virus Diseases Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases Mycobacterium Infections Actinomycetales Infections Gram-Positive Bacterial Infections Bacterial Infections Ritonavir Indinavir Rifampin HIV Protease Inhibitors Protease Inhibitors Enzyme Inhibitors Molecular Mechanisms of Pharmacological Action Anti-HIV Agents Anti-Retroviral Agents Antiviral Agents Anti-Infective Agents (...) The Pharmacokinetics and Safety of IDV/r With NRTIs in HIV/TB Co-infected Patients Receiving Rifampicin The Pharmacokinetics and Safety of IDV/r With NRTIs in HIV/TB Co-infected Patients Receiving Rifampicin - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100

2006 Clinical Trials

4172. A Network Intervention for Prevention of HIV Infection in Chennai, India

-1 First Posted: September 22, 2005 Last Update Posted: September 1, 2015 Last Verified: August 2015 Keywords provided by Carl Latkin, Johns Hopkins Bloomberg School of Public Health: HIV injection drug use social networks Additional relevant MeSH terms: Layout table for MeSH terms Infection HIV Infections Acquired Immunodeficiency Syndrome Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases (...) A Network Intervention for Prevention of HIV Infection in Chennai, India A Network Intervention for Prevention of HIV Infection in Chennai, India - 1 - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more

2005 Clinical Trials

4173. Examining Factors That May Influence Resistance to HIV-1 Infection

/AIDS Vaccine Immunology Information provided by (Responsible Party): National Institute of Allergy and Infectious Diseases (NIAID) Study Details Study Description Go to Brief Summary: Some people who are exposed to the HIV-1 virus are capable of either controlling or completely preventing viral infection. Multiple genetic factors may contribute to preventing or controlling HIV-1 infection. The purpose of this study is to analyze the immune system responses of individuals who are exposed to HIV-1 (...) information Responsible Party: National Institute of Allergy and Infectious Diseases (NIAID) ClinicalTrials.gov Identifier: Other Study ID Numbers: CHAVI 002 10464 ( Registry Identifier: DAIDS-ES ) First Posted: July 12, 2006 Last Update Posted: April 9, 2014 Last Verified: April 2014 Keywords provided by National Institute of Allergy and Infectious Diseases (NIAID): Host Resistance Additional relevant MeSH terms: Layout table for MeSH terms Infection Communicable Diseases HIV Infections Lentivirus

2006 Clinical Trials

4174. Preventive Therapy for Tuberculosis in HIV Infected Persons

of TB and overall mortality will be compared in each group. Study Endpoints:The primary end point of the study will be development of tuberculosis and the secondary endpoints will include adverse drug reactions and mortality rate. Condition or disease Intervention/treatment Phase Human Immunodeficiency Virus Tuberculosis Drug: Isoniazid with Ethambutol Phase 3 Detailed Description: Study population and enrollment: All HIV positive patients seeking care at one of the study centers, above the age (...) Soumya Swaminathan, Tuberculosis Research Centre, India: Preventive therapy Additional relevant MeSH terms: Layout table for MeSH terms Immunologic Deficiency Syndromes Tuberculosis Acquired Immunodeficiency Syndrome HIV Infections Immune System Diseases Mycobacterium Infections Actinomycetales Infections Gram-Positive Bacterial Infections Bacterial Infections Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases Sexually Transmitted Diseases, Viral Sexually Transmitted

2006 Clinical Trials

4175. Evaluating Host and Viral Factors Among HIV Infected Former Commercial Blood Donors in Fuyang, Anhui Province, China

of Allergy and Infectious Diseases (NIAID): Former Plasma Donors Commercial Plasma Donors Long-Term Nonprogressors Host Factors Viral Factors HIV Additional relevant MeSH terms: Layout table for MeSH terms HIV Infections Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases (...) 30, 2006 Last Update Posted : May 19, 2014 Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Collaborator: Comprehensive International Program of Research on AIDS Information provided by (Responsible Party): National Institute of Allergy and Infectious Diseases (NIAID) Study Details Study Description Go to Brief Summary: HIV infected former commercial blood donors (FBDs) in Fuyang, Anhui Province, China were infected with HIV from a common-source exposure to contaminated

2006 Clinical Trials

4176. Omega-3 Fatty Acids for High Triglycerides in HIV-infected Patients

of markers of bone turnover and inflammation. It is 8- week randomized, double-blind trial of omega-3 fatty acids (LOVAZA, GSK, Inc) compared to placebo in 48 HAART-treated HIV-infected patients with triglycerides between 250 and 1000 mg/dl receiving dietary counseling. Subjects will be recruited from three centers (Johns Hopkins, Georgetown, and Los Angeles VAMC). The primary endpoint will be the change in triglyceride concentrations from baseline in the LOVAZA group compared to the placebo group (...) inflammation insulin resistance Additional relevant MeSH terms: Layout table for MeSH terms HIV Infections Dyslipidemias Hypertriglyceridemia Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases Lipid Metabolism Disorders Metabolic Diseases Hyperlipidemias

2006 Clinical Trials

4177. A Randomized Trial of IUD Versus Hormonal Contraception in HIV-infected Women in Zambia

that approximately 30% of reproductive age women in Lusaka are HIV-infected. Since voluntary HIV counseling and testing is not yet universally available in many of the district clinics, women receive all different types of contraception regardless of their HIV status. There is some observational data published recently that suggests hormonal contraception may increase HIV viral load in the female genital tract and potentially increase HIV transmission to the male partner. By contrast, barrier methods have (...) historically been very unpopular in stable couples and are not used consistently in many cases despite intensive counseling. The IUCD represents one of the most inexpensive and effective methods of birth control available in Lusaka. However, it has not been studied adequately to make policy recommendations regarding its use in HIV infected women. The purpose of this study will be to evaluate safety and acceptability of the IUCD versus hormonal methods of contraception in HIV-infected and uninfected women

2006 Clinical Trials

4178. Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV Infection

for MeSH terms Infection Communicable Diseases HIV Infections Acquired Immunodeficiency Syndrome Gonorrhea Herpes Genitalis Chlamydia Infections Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases Slow Virus Diseases Neisseriaceae Infections Gram-Negative Bacterial Infections Bacterial Infections Sexually Transmitted Diseases, Bacterial Genital (...) Drug: Placebo Phase 3 Detailed Description: The HIV pandemic continues with an estimated 13,000 new infections each day, the vast majority of which are acquired through heterosexual intercourse. Although consistent and correct use of condoms by men remains the most effective form of protection from heterosexually acquired HIV, women are not always able to negotiate condom use. An effective prophylactic vaccine remains a key objective, but development is slow because of virus variability

2005 Clinical Trials

4179. Prevalence of HIV and Other Sexually Transmitted Infections Among Female Sex Workers and Miners in Honghe Prefecture, Yunnan Province, China

Verified: January 2011 Additional relevant MeSH terms: Layout table for MeSH terms Infection Communicable Diseases HIV Infections Sexually Transmitted Diseases Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases Sexually Transmitted Diseases, Viral Immunologic Deficiency Syndromes Immune System Diseases Genital Diseases, Male Genital Diseases, Female (...) will identify potential participants for future studies. Condition or disease Intervention/treatment HIV Infections Sexually Transmitted Diseases Behavioral: Cross-sectional surveys Behavioral: Questionnaire/counseling Detailed Description: The overwhelming majority of HIV/AIDS patients live in the developing world. The rate of HIV infection in China has been consistently and steadily increasing over the past few years. Commercial sex workers and their clients are at highest risk for HIV infection

2006 Clinical Trials

4180. Effect of Medication Diaries on Adherence to Highly Active Antiretroviral Drugs Among HIV-1 Infected Kenyan Children

a randomized control trial to determine the effect of medication diaries and counseling versus counseling alone on HAART-adherence in HIV-1 infected children and their parents/caregivers in Nairobi Kenya. Condition or disease Intervention/treatment Phase HIV Infections Behavioral: Medication diaries Phase 2 Detailed Description: Study design: This is a randomized trial comparing adherence to antiretroviral drugs and clinical outcomes between 50 HIV-1 infected Kenyan children randomized to a simple (...) medication diary plus standard counseling with a similar group of children randomized to counseling alone. Study procedures: Parents or caregivers of HIV-1 infected children discharged from the Kenyatta National Hospital (KNH) children's wards or seen in pediatric outpatient clinics will be invited to participate in the study by nurse counselors. Informed written consent will be obtained from those who meet eligibility criteria and agree to participate. The consenting process will be done

2005 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>